Assay ID | Title | Year | Journal | Article |
AID89116 | Effective dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID141914 | Effective dose required to inhibit MSV-induced transformation in murine C3H cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID297672 | Antimycobacterial activity against Mycobacterium tuberculosis H37Ra at 100 uM by microplate alamar blue assay | 2007 | Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
| Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. |
AID297676 | Antimycobacterial activity against Mycobacterium bovis BCG at 100 uM by microplate alamar blue assay | 2007 | Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
| Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. |
AID28386 | Partition coefficient in 1-octanol and 10 mM aqueous potassium phosphate buffer at pH 7.4 | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID297680 | Antimycobacterial activity against Mycobacterium avium ATCC 25291 at 100 uM by microplate alamar blue assay | 2007 | Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
| Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. |
AID232359 | Ratio of CD50 and ED50 values against inhibition of HIV in MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID89115 | Cytotoxic dose required to inhibit HIV-induced cytopathogenicity in human MT-4 cells | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID141915 | Toxic dose required to cause an alteration of normal C3H cell morphology | 1989 | Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
| Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. |
AID31902 | In vitro cytotoxicity against uninfected ATH-8 (human T-cell) cell line. | 1992 | Journal of medicinal chemistry, Jun-26, Volume: 35, Issue:13
| Synthesis and anti-HIV activity of isonucleosides. |
AID297677 | Antimycobacterial activity against Mycobacterium bovis BCG at 50 uM by microplate alamar blue assay | 2007 | Journal of medicinal chemistry, Sep-20, Volume: 50, Issue:19
| Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. |
AID31903 | In vitro effective dose which provides 50% protection of ATH-8 cells against the cytopathic effect of HIV | 1992 | Journal of medicinal chemistry, Jun-26, Volume: 35, Issue:13
| Synthesis and anti-HIV activity of isonucleosides. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |